Yubo International Biotech Ltd (YBGJ)
0.0905
-0.04
(-32.86%)
USD |
OTCM |
Nov 14, 13:05
Yubo International Biotech Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0035M |
| December 31, 2023 | 0.0223M |
| September 30, 2023 | 0.4285M |
| June 30, 2023 | 0.0014M |
| March 31, 2023 | 0.1566M |
| December 31, 2022 | 0.0665M |
| September 30, 2022 | 0.0146M |
| June 30, 2022 | 0.008M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0152M |
| December 31, 2021 | 0.3323M |
| September 30, 2021 | 0.0983M |
| June 30, 2021 | 0.3515M |
| March 31, 2021 | 0.4623M |
| December 31, 2020 | 0.8827M |
| September 30, 2020 | 0.1945M |
| June 30, 2020 | 0.2767M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0014M
Minimum
Jun 2023
0.8827M
Maximum
Dec 2020
0.2072M
Average
0.1275M
Median
Revenue (Quarterly) Benchmarks
| Hologic Inc | 987.90M |
| Nuwellis Inc | 2.194M |
| Linike Medical Group Ltd | -- |
| Varex Imaging Corp | 209.10M |
| Quanterix Corp | 34.13M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5275M |
| Total Expenses (Quarterly) | 0.4704M |
| EPS Diluted (Quarterly) | -0.0044 |
| Enterprise Value | 16.25M |
| Earnings Yield | -8.58% |
| Normalized Earnings Yield | -7.106 |